Chemoinformaics analysis of 2,4-Dimethylbenzaldehyde
| Molecular Weight | 134.178 | nRot | 1 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 9 |
| Exact Molecular Weight | 134.073 | nRing | 1 |
| Solubility: LogS | -4.371 | nHRing | 0 |
| Solubility: LogP | 3.962 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 22.4999 |
| nHD | 0 | BPOL | 10.9001 |
| QED | 0.449 |
| Synth | 3.405 |
| Natural Product Likeliness | 0.6 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.014 |
| HIA | 0.007 |
| CACO-2 | -4.369 |
| MDCK | 0.00002 |
| BBB | 0.961 |
| PPB | 0.962904 |
| VDSS | 4.304 |
| FU | 0.0390013 |
| CYP1A2-inh | 0.88 |
| CYP1A2-sub | 0.915 |
| CYP2c19-inh | 0.379 |
| CYP2c19-sub | 0.896 |
| CYP2c9-inh | 0.341 |
| CYP2c9-sub | 0.8 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.151 |
| CYP3a4-inh | 0.078 |
| CYP3a4-sub | 0.399 |
| CL | 11.836 |
| T12 | 0.074 |
| hERG | 0.012 |
| Ames | 0.035 |
| ROA | 0.101 |
| SkinSen | 0.077 |
| Carcinogencity | 0.53 |
| EI | 0.954 |
| Respiratory | 0.917 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.898329 |